The CSF levels of amyloid-β42 in the MDD group were significantly lower than those of the control group, whereas differences in CSF levels of amyloid-β40, total and phosphorylated tau protein did not differ across conditions (Table 1). Here, MAPT is linked to major depressive disorder.